本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

75.15
-1.4300-1.87%
盤後75.150.00000.00%19:30 EDT
成交量:48.89萬
成交額:3,669.69萬
市值:58.64億
市盈率:75.91
高:76.63
開:76.46
低:74.47
收:76.58
52周最高:82.94
52周最低:35.20
股本:7,802.40萬
流通股本:3,994.15萬
量比:0.83
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
淨資產收益率:14.04%
總資產收益率:8.05%
市淨率:8.96
市盈率(LYR):100.20

資料載入中...

2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/23

重要事件披露

Form 8-K - Current report
2025/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]